Anzeige
Mehr »
Login
Montag, 31.03.2025 Börsentäglich über 12.000 News von 696 internationalen Medien
Ad-hoc-Meldung: Gleich zu Wochenbeginn prozentual dreistellig? Der frühe Vogel…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A403QV | ISIN: FR001400OLP5 | Ticker-Symbol: 6XB3
Frankfurt
28.03.25
21:47 Uhr
0,195 Euro
-0,009
-4,51 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
BIOPHYTIS SA Chart 1 Jahr
5-Tage-Chart
BIOPHYTIS SA 5-Tage-Chart
RealtimeGeldBriefZeit
0,2050,21730.03.

Aktuelle News zur BIOPHYTIS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrBIOPHYTIS: Biophytis announces the settlement and delivery of its €2.6 million private placement2
BIOPHYTIS Aktie jetzt für 0€ handeln
MiBIOPHYTIS: Biophytis announces the successful completion of a €2,6 million private placement5
24.03.BIOPHYTIS: Biophytis announces new non-clinical data further supporting its mission to pioneer the restoration of mobility in patients with obesity3
24.03.Biophytis Announces New Non-Clinical Data Further Supporting Its Mission to Pioneer the Restoration of Mobility in Patients with Obesity21096% of patients with obesity report experiencing muscle strength impairment, affecting their mobilityNew preclinical study results: The combination of BIO101 and GLP-1 induced muscle strength and mobility...
► Artikel lesen
20.03.Biophytis SA - 6-K, Report of foreign issuer3
17.03.BIOPHYTIS: Biophytis revolutionizes sarcopenia3
17.03.Biophytis Revolutionizes Sarcopenia252Publication of SARA-INT Phase II results for BIO101Confirmation of Phase 3 readinessParis, France and Cambridge, Massachusetts--(Newsfile Corp. - March 17, 2025) - Biophytis SA (FP: ALBPS) ("Biophytis"...
► Artikel lesen
06.03.BIOPHYTIS: Biophytis announces its participation to the BIO-Europe Spring 2025 in Milan6
25.02.BIOPHYTIS: Biophytis announces its participation in the 15th International Conference on Frailty and Sarcopenia Research (ICFSR)4
25.02.Biophytis Announces its Participation in the 15th International Conference on Frailty and Sarcopenia Research (ICFSR)292Paris, France and Cambridge, Massachusetts--(Newsfile Corp. - February 25, 2025) - Biophytis SA (FP: ALBPS) ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in the...
► Artikel lesen
11.02.Biophytis unveils outlook strategies for 2025, to launch phase 3 of SARA clinical program4
11.02.BIOPHYTIS: Biophytis unveils its outlook strategies for 20253
11.02.Biophytis Unveils Its Outlook Strategies for 2025303Paris, France and Cambridge, Massachusetts--(Newsfile Corp. - February 11, 2025) - Biophytis SA (FP: ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in the...
► Artikel lesen
27.01.BIOPHYTIS: Biophytis announces its participation to the BIOMED FORUM investor conference2
27.01.Biophytis Announces Its Participation to the BIOMED FORUM Investor Conference304Paris, France and Cambridge, Massachusetts--(Newsfile Corp. - January 27, 2025) - Biophytis SA (FP: ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in the...
► Artikel lesen
21.01.BIOPHYTIS: Biophytis and AskHelpU Sign a Co-Development Agreement in Rare Neuromuscular Diseases in China1
21.01.Biophytis and AskHelpU Sign a Co-Development Agreement in Rare Neuromuscular Diseases in China335Paris, France and Cambridge, Massachusetts--(Newsfile Corp. - January 21, 2025) - Biophytis SA (FP: ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in the...
► Artikel lesen
14.01.Biophytis SA - 6-K, Report of foreign issuer1
14.01.BIOPHYTIS: Biophytis Enters Exclusive Negotiations with a Chinese Pharmaceutical Company to License BIO1012
14.01.Biophytis Enters Exclusive Negotiations with a Chinese Pharmaceutical Company to License BIO101369Paris, France and Cambridge, Massachusetts--(Newsfile Corp. - January 14, 2025) - Biophytis SA (OTC Pink: BPTSY) (FP: ALBPS) ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing...
► Artikel lesen
Seite:  Weiter >>
53 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1